Richard Nkulikiyinka

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial.

Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial.

Journal: European heart journal

Published: December 02, 2024

Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial.

Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial.

Journal: Journal of cardiac failure

Published: May 17, 2024

Where's the Remote? Failure to Report Clinical Workflows in Heart Failure Remote Monitoring Studies.

Where's the Remote? Failure to Report Clinical Workflows in Heart Failure Remote Monitoring Studies.

Journal: Journal of cardiac failure

Published: February 07, 2024

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.

Journal: Journal of the American Society of Nephrology : JASN

Published: October 09, 2023

Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.

Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.

Journal: American heart journal

Published: April 20, 2023

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.

Journal: Journal of the American Society of Nephrology : JASN

Published: April 19, 2023

Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.

Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.

Journal: JACC. Heart failure

Published: March 14, 2023

Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation.

Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation.

Journal: Digital biomarkers

Published: February 11, 2023

Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators.

Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators.

Journal: Current problems in cardiology

Published: November 23, 2022

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory.

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory.

Journal: JACC. Heart failure

Published: November 15, 2022

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.

Journal: Circulation. Heart failure

Published: June 03, 2022

Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.

Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.

Journal: JACC. Heart failure

Published: May 18, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026